Orthofix International reported $39.83M in Ordinary Share Capital for its fiscal quarter ending in December of 2025.





Ordinary Share Capital Change Date
Accuray USD 100K 1000 Sep/2024
AngioDynamics USD 41.57M 127K Sep/2025
Artivion USD 47.84M 468K Dec/2025
AtriCure USD 49.7M 10K Sep/2025
Dexcom USD 384.8M 5.2M Dec/2025
EDAP TMS EUR 37.39M 0 Sep/2025
Globus Medical USD 135.06M 449K Dec/2025
Hologic USD 222.57M 350K Sep/2025
Inogen USD 23K 0 Dec/2023
Insulet USD 70.35M 1000 Dec/2025
Integra LifeSciences USD 77.89M 34K Dec/2025
J&J USD 2.41B 584K Sep/2025
Medtronic USD 1.28B 1.38M Dec/2025
Mesa Laboratories USD 349.53M 3.53M Sep/2024
Orthofix International USD 39.83M 315K Dec/2025
Smith & Nephew USD 875.96M 1.61M Dec/2025
STAAR Surgical USD 49.4M 49K Dec/2025
Stryker USD 382.4M 93K Dec/2025
Surmodics USD 716K 4K Sep/2024
Tandem Diabetes Care USD 68.29M 518K Dec/2025
Teleflex USD 44.19M 1000 Dec/2025
Veracyte USD 79.05M 377K Dec/2025
Zimmer Biomet Holdings USD 198.18M 18.44K Dec/2025